Canada (EN)
CLINICAL CASE
Immediate loading of post extractive single tooth in esthetic zone with simultaneous GBR
Dr. Fabrizio Colombo
Initial clinical situation
Front view (left) and Buccal view (right).
Detail of the typical buccal convex architecture in the area of 24. Frontal view (left).
Detail of the typical buccal convex architecture in the area of 24. Occlusal view (center).
Pre-operative X-ray (right).
Surgical procedure
Loss of the palatal wall of the crown on 24 (left).
Vertical fracture on 24 (right).
Detail of 24 after extraction; presence of two vestibular roots and an accidental fracture of the buccal bone plate (left).
Leveling and cleaning of the buccal wall (right).
Detail of the implant site preparation in the alveolus palatal region. The interradicular septum has become the new buccal cortical bone around the implant (left).
NobelReplace® CC 4.3 x 11.5 mm insertion (35 Ncm) (right).
Occlusal detail of the implant placement (left).
The socket is filled using creos™ xenogain 0.5 g small granules (right).
Insertion of the graft in the buccal socket (left).
View of the biomaterial placed (center).
Temporary protection of the graft with fibrin sponge (right).
Impression phase (left)
X-ray taken during the impression phase (right).
Restorative procedure
Detail of the impression (Impregum 3M ESPE) (left).
Temporary screwed crown a few days after surgical phase (center).
Temporary crown X-ray (right).
Outcome
Final clinical situation of the gingival tunnel (occlusal view). Detail of the buccal convex architecture (7 months after implant placement) (left).
Final zirconia screwed crown (occlusal view) (right).
Final ceramic screwed crown (lateral view, 7 months after implant placement).
CBCT 7 months after the implant placement.
Share this clinical case
© Nobel Biocare Services AG, 2023. All rights reserved. Distributed by: Nobel Biocare. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information. Product images are not necessarily to scale. All product images are for illustration purposes only and may not be an exact representation of the product. Please contact the local Nobel Biocare sales office for current product assortment and availability. Disclaimer: For prescription use only. Caution: Federal (United States) law or the law in your jurisdiction may restrict this device to sale by or on the order of a licensed clinician, medical professional or physician. See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions. OCS-B (Nibec Co., Ltd.) is distributed as creos™ xenogain since September 2016. Legal Manufacturer: Nibec Co., Ltd. Iwol electricity-electronic Agro-industrial Complex, 116 Bamdi-gil, Iwol-myeon, Jincheon-gun, Chungcheongbuk-do, 27816 Korea. Nobel Biocare does not take any liability for any injury or damage to any person or property arising from the use of this clinical case. This clinical case is not intended to recommend any measures, techniques, procedures or products, or give advice, and is not a substitute for medical training or your own clinical judgement as a healthcare professional. Viewers should never disregard professional medical advice or delay seeking medical treatment because of something they have seen in this clinical case. Full procedure is not shown. Certain sequences have been cut.